TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 DBMR VENDOR SHARE ANALYSIS
2.9 MULTIVARIATE MODELING
2.10 PRODUCT TIMELINE CURVE
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING CASES OF CHRONIC WOUNDS
3.1.2 NEW PRODUCT LAUNCHES
3.1.3 INCREASING NUMBER OF PATIENTS UNDERGOING SURGICAL PROCEDURES
3.1.4 GROWING GERIATRIC POPULATION
3.1.5 RISING AWARENESS PROGRAMS
3.1.6 INCREASING RESEARCH AND DEVELOPMENT
3.2 RESTRAINTS
3.2.1 HIGH COST ASSOCIATED WITH THE TREATMENT
3.2.2 STRINGENT MANUFACTURING POLICIES
3.2.3 PRODUCT RECALL
3.3 OPPORTUNITIES
3.3.1 TECHNOLOGICAL ADVANCEMENT IN WOUND CARE
3.3.2 GROWTH POTENTIAL IN EMERGING ECONOMIES
3.3.3 STRATEGIC INITIATIVES BY THE COMPANIES
3.4 CHALLENGES
3.4.1 LACK OF SKILLED LABOR FORCE
3.4.2 SIDE EFFECTS AND ADVERSE EFFECTS ASSOCIATED WITH CHRONIC WOUNDS
4 EXECUTIVE SUMMARY
5 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.1.1 DRESSING
5.1.1.1 FOAM DRESSING
5.1.1.2 FILM DRESSING
5.1.1.3 ALGINATE DRESSING
5.1.1.4 HYDROCOLLOID DRESSING
5.1.1.5 HYDROGEL DRESSING
5.1.1.6 COLLAGEN DRESSING
5.1.1.7 OTHERS
5.1.2 THERAPY DEVICES
5.1.2.1 NEGATIVE PRESSURE WOUND THERAPY (NPWT)
5.1.2.1.1 DISPOSABLE NPWT DEVICES
5.1.2.1.2 PORTABLE NPWT DEVICES
5.1.2.2 PHYSICAL THERAPIES
5.1.2.2.1 LASER THERAPY
5.1.2.2.2 EXTERNAL SHOCK WAVE THERAPIES
5.1.2.2.3 ELECTRICAL STIMULATION
5.1.2.2.4 OTHERS
5.1.2.3 PRESSURE RELIEF DEVICES
5.1.2.4 HYPERBARIC OXYGEN CHAMBERS
5.1.2.4.1 MONOPLACE
5.1.2.4.2 MULTIPLACE
5.1.2.5 WOUND DEBRIDEMENT DEVICES
5.1.2.5.1 ULTRASOUND
5.1.2.5.2 HYDROSURGICAL
5.1.2.5.3 MECHANICAL
5.1.2.5.4 OTHERS
5.1.2.5.5 OTHERS
5.1.3 BIOLOGICS
5.1.3.1 ALLOGRAFTS
5.1.3.2 XENOGRAFTS
5.1.3.3 SYNTHETIC SKIN GRAFTS
5.1.3.4 GROWTH FACTORS
5.1.3.5 PLATELET DERIVED GROWTH FACTOR (PDGF)
5.1.3.6 PLATELET RICH PLASMA (PRP)
5.1.3.7 OTHERS
5.1.4 OTHERS
6 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET, BY TYPE OF DRESSINGS
6.1 OVERVIEW
6.1.1 PRIMARY
6.1.2 SECONDARY
7 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET, BY WOUND TYPE
7.1 OVERVIEW
7.1.1 SURGICAL WOUNDS
7.1.1.1 CLASS III
7.1.1.2 CLASS IV
7.1.1.3 CLASS II
7.1.1.4 CLASS I
7.1.2 ULCERS
7.1.2.1 DIABETIC FOOT ULCERS
7.1.2.2 VENOUS ULCERS
7.1.2.3 PRESSURE ULCERS
7.1.2.4 ARTERIAL LEG ULCERS
7.1.2.5 OTHERS
7.1.3 TRAUMA WOUNDS
7.1.4 BURNS
7.1.5 OTHERS
8 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET, BY END USER
8.1 OVERVIEW
8.1.1 HOSPITALS
8.1.2 WOUND CARE CENTERS
8.1.3 AMBULATORY CENTERS
8.1.4 HOME HEALTHCARE
8.1.5 CLINICS
8.1.6 COMMUNITY HEALTHCARE
?
9 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.1.1 DIRECT TENDERS
9.1.2 RETAIL
10 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET, BY GEOGRAPHY
10.1 MIDDLE EAST & AFRICA
10.1.1 SOUTH AFRICA
10.1.2 REST OF MIDDLE EAST & AFRICA
10.1.3 EGYPT
10.1.4 SAUDI ARABOIA
10.1.5 UNITED ARAB EMIRATES
10.1.6 ISRAEL
11 MIDDLE EAST & AFRICA ADVANCED WOUND CARE MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
12 COMPANY PROFILE
12.1 SMITH & NEPHEW
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 3M
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 MEDLINE INDUSTRIES, INC.
12.3.1 COMPANY SNAPSHOT
12.3.2 COMPANY SHARE ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 RECENT DEVELOPMENT
?
12.4 MoLNLYCKE HEALTH CARE AB
12.4.1 COMPANY SNAPSHOT
12.4.2 COMPANY SHARE ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 RECENT DEVELOPMENTS
12.5 CONVATEC GROUP PLC
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 ADVANCED MEDICAL SOLUTIONS GROUP PLC
12.6.1 COMPANY SNAPSHOT
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENT
12.7 ADVANCIS MEDICAL UK
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENT
12.8 AVERY DENNISON CORPORATION
12.8.1 COMPANY SNAPSHOT
12.8.2 REVENUE ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENTS
12.9 B. BRAUN MELSUNGEN AG
12.9.1 COMPANY SNAPSHOT
12.9.2 REVENUE ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENTS
12.10 BAXTER
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENT
12.11 CARDINAL HEALTH
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 COLOPLAST GROUP
12.12.1 COMPANY SNAPSHOT
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 HOLLISTER INCORPORATED
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENT
12.14 JOHNSON & JOHNSON SERVICES, INC.
12.14.1 COMPANY SNAPSHOT
12.14.2 REVENUE ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 RECENT DEVELOPMENT
12.15 INTEGRA LIFESCIENCES CORPORATION
12.15.1 COMPANY SNAPSHOT
12.15.2 REVENUE ANALYSIS
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENTS
12.16 MEDTRONIC
12.16.1 COMPANY SNAPSHOT
12.16.2 REVENUE ANALYSIS
12.16.3 PRODUCT PORTFOLIO
12.16.4 RECENT DEVELOPMENT
12.17 MIMEDX
12.17.1 COMPANY SNAPSHOT
12.17.2 PRODUCT PORTFOLIO
12.17.3 RECENT DEVELOPMENTS
12.18 ORGANOGENESIS INC.
12.18.1 COMPANY SNAPSHOT
12.18.2 REVENUE ANALYSIS
12.18.3 PRODUCT PORTFOLIO
12.18.4 RECENT DEVELOPMENTS
12.19 PAUL HARTMANN LIMITED
12.19.1 COMPANY SNAPSHOT
12.19.2 PRODUCT PORTFOLIO
12.19.3 RECENT DEVELOPMENT
?
12.20 ZIMMER BIOMET
12.20.1 COMPANY SNAPSHOT
12.20.2 REVENUE ANALYSIS
12.20.3 PRODUCT PORTFOLIO
12.20.4 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS